Table 5.
Baseline characteristics for diabetic subset
| Variable | Group 1: Diabetic HFpEF (n = 43) | Group 2: Diabetic Diastolic Dysfunction (n = 21) | p-value |
|---|---|---|---|
| Age (years) | 66.0 ± 9.40 | 66.9 ± 10.2 | 0.73 |
| Gender (% Female) | 65.1 | 71.4 | 0.61 |
| Race (% African American) | 34.9 | 28.6 | 0.61 |
| Body Surface Area (m2) | 2.0 ± 0.3 | 2.0 ± 0.2 | 0.19 |
| Tobacco Use (%) | 65.9 | 66.7 | 0.95 |
| Alcohol Use (%) | 37.5 | 57.1 | 0.14 |
| Hypertension (%) | 95.3 | 85.7 | 0.18 |
| Coronary Artery Disease (%) | 72.1 | 47.6 | 0.06 |
| Atrial Fibrillation (%) | 30.2 | 14.3 | 0.17 |
| Beta Blockers (%) | 79.1 | 57.1 | 0.07 |
| Calcium Channel Blockers (%) | 32.6 | 23.8 | 0.47 |
| ACE Inhibitors (%) | 27.9 | 14.3 | 0.23 |
| Angiotensin Receptor Blockers (%) | 27.9 | 28.6 | 0.96 |
| Mild Diastolic Dysfunction (%) | 23.3 | 9.5 | 0.16* |
| Moderate Diastolic Dysfunction (%) | 76.7 | 85.7 | |
| Severe Diastolic Dysfunction (%) | 0.0 | 4.8 |
Note: Continuous data expressed as mean ± standard deviation. Categorical variables expressed as percentage
* p-value calculated using Fisher’s Exact Test for a 2x3 contingency table